Functional characterization of human oncoprotein gankyrin in Zebrafish

Experimental and Molecular Medicine

Volumn 41, Issue 1, 2009, Pages 8-16

  So, Yeon Kim ^a   Hur, Wonhee ^a   Choi, Jung Eun ^a   Kim, Daniel ^a   Jin, Sang Wang ^a   Yoon, Hye Yeon ^b   Piao, Lian Shu ^a   Seung, Kew Yoon ^a  

^a The Catholic University of Korea   (South Korea)

^b Ewha Womans University   (South Korea)

Author keywords

Cell proliferation; Proto oncogene proteins c mdm2; PSMD10 protein, human; Tumor suppressor protein p53; Zebrafish

Indexed keywords

GANKYRIN; GREEN FLUORESCENT PROTEIN; ONCOPROTEIN; PROTEIN MDM2; PROTEIN P53; UNCLASSIFIED DRUG; MDM2 PROTEIN, HUMAN; PROTEASOME; PSMD10 PROTEIN, HUMAN;

ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; NONHUMAN; NORTHERN BLOTTING; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ZEBRA FISH; ANIMAL; ANIMAL MODEL; CELL LINE; CELL SURVIVAL; GENE EXPRESSION; GENETICS; METABOLISM;

DANIO RERIO;

ANIMALS; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; GENE EXPRESSION; HUMANS; IN SITU HYBRIDIZATION; MODELS, ANIMAL; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; TUMOR SUPPRESSOR PROTEIN P53; ZEBRAFISH;

EID: 63849301677     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.3858/emm.2009.41.1.002     Document Type: Article

References (20)

1. Amatruda JF, Shepard JL, Stern HM, Zon LI. Zebrafish as a cancer model system. Cancer Cell 2002;1:229-231 (Pubitemid 41039146)
2. Brown JP, Pagano M. Mechanism of p53 degradation. Biochim Biophys Acta 1997;1332:O1-6 (Pubitemid 27211622)
3. Cheng R, Wu JL. Gene expression of insulin-like growth factor-I receptor and p53 suppressor during zebrafish (Danio rerio) embryogenesis. Mar Biotechnol (NY) 2002;4:226-235
4. Daujat S, Neel H, Piette J. MDM2: life without p53. Trends Genet 2001;17:459-464 (Pubitemid 32727238)
5. Higashitsuji H, Itoh K, Nagao T, Dawson S, Nonoguchi K, Kido T, Mayer RJ, Arii S, Fujita J. Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas. Nat Med 2000;6:96-99 (Pubitemid 30048534)
6. Higashitsuji H, Higashitsuji H, Itoh K, Sakurai T, Nagao T, Sumitomo Y, Masuda T, Dawson S, Shimada Y, Mayer RJ, Fujita J. The oncoprotein gankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53. Cancer Cell 2005;8:75-87 (Pubitemid 40991816)
7. Hori T, Kato S, Saeki M, DeMartino GN, Slaughter CA, Takeuchi J, Toh-e A, Tanaka K. cDNA cloning and functional analysis of p28 (Nas6p) and p40.5 (Nas7p), two novel regulatory subunits of the 26S proteasome. Gene 1998; 216:113-122 (Pubitemid 28389108)
8. Iwai A, Marusawa H, Kiuchi T, Higashitsuji H, Tanaka K, Fujita J, Chiba T. Role of a novel oncogenic protein, gankyrin, in hepatocyte proliferation. J Gastroenterol 2003;38:751-758 (Pubitemid 37161339)
9. Krzywda S, Brzozowski AM, Higashitsuji H, Fujita J, Welchman R, Dawson S, Mayer RJ, Wilkinson AJ. The crystal structure of gankyrin, an oncoprotein found in complexes with cyclin-dependent kinase 4, a 19 S proteasomal ATPase regulator, and the tumor suppressors Rb and p53. J Biol Chem 2004;279:1541-1545 (Pubitemid 38082684)
10. Langheinrich U, Hennen E, Stott G, Vacun G. Zebrafish as a model organism for the identification and characterization of drugs and genes affecting p53 signaling. Curr Biol 2002;12:2023-2028 (Pubitemid 35450925)
11. Li J, sai MD. Novel insights into the INK4-CDK4/6-Rb pathway: counter action of gankyrin against INK4 proteins regulates the CDK4-mediated phosphorylation of Rb. Biochemistry 2002;41:3977-3983
12. Liu TX, Howlett NG, Deng M, Langenau DM, Hsu K, Rhodes J, Kanki JP, D'Andrea AD, Look AT. Knockdown of zebrafish Fancd2 causes developmental abnormalities via p53-dependent apoptosis. Dev Cell 2003;5:903-914 (Pubitemid 37527690)
13. Lozano G, Zambetti GP. Gankyrin: an intriguing name for a novel regulator of p53 and RB. Cancer Cell 2005;8:3-4 (Pubitemid 40991808)
14. Meek DW. The p53 response to DNA damage. DNA Repair (Amst) 2004;3:1049-1056 (Pubitemid 38997947)
15. Nowak M, Koster C, Hammerschmidt M. Perp is required for tissue-specific cell survival during zebrafish development. Cell Death Differ 2005;12:52-64 (Pubitemid 40090028)
16. Park TJ, Kim HS, Byun KH, Jang JJ, Lee YS, Lim IK. Sequential changes in hepatocarcinogenesis induced by diethylnitrosamine plus thioacetamide in Fischer 344 rats: induction of gankyrin expression in liver fibrosis, pRB degradation in cirrhosis, and methylation of p16(INK4A) exon 1 in hepatocellular carcinoma. Mol Carcinog 2001;30:138-150 (Pubitemid 32274077)
17. Qin JM, Yan HX, Wan XW, Liu SQ, Zeng JZ, Cao HF, Wu MC, Wang HY. Effects of signal regulatory proteinalpha1 on proliferation of hepatocellular carcinoma: a preliminary study. Hepatobiliary Pancreat Dis Int 2005;4:244-248 (Pubitemid 40790173)
18. Thisse C, Neel H, Thisse B, Daujat S, Piette J. The Mdm2 gene of zebrafish (Danio rerio): preferential expression during development of neural and muscular tissues, and absence of tumor formation after overexpression of its cDNA during early embryogenesis. Differentiation 2000;66:61-70
19. Westerfield M. The zebrafish Book : A Guide for Laborator use of Zebrafish (Danio rerio). University of Oregon Press, Eugene, OR 1995
20. Yang HW, Kutok JL, Lee NH, Piao HY, Fletcher CD, Kanki JP, Look AT. Targeted expression of human MYCN selectively causes pancreatic neuroendocrine tumors in transgenic zebrafish. Cancer Res 2004;64:7256-7262 (Pubitemid 39372062)